PREDICT overview

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence (AI) company transforming oncology drug discovery and development, today announced the launch of an innovative AI-powered module within its proprietary RADR ® platform, designed to predict the activity and efficacy of combination regimens involving DNA-damaging agents (DDAs) and DNA damage response inhibitors (DDRis) in clinical cancer treatment. With the global market for combination cancer therapies projected to exceed...

Israel is on heightened alert after the U.S. strikes on three nuclear sites in #Iran, NBC News Chief Foreign Correspondent Richard ......

Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights - the first ever UKCA-marked and MHRA registered test that combines genetic and clinical factors to predict and prevent common diseases PR Newswire OXFORD, England, June 17, 2025 Health Insights UK is Genomics' predictive clinical tool. It provides genetic risk testing as a secure, end-to-end solution based on a saliva sample that can be collected at home. The test provides doctors with their...

The chancellor is set to present her spending review to parliament on 11 June, setting the budget for every government ......

Latest news bulletin | May 2nd – Midday Catch up with the most important stories from around Europe and beyond - latest news, ......

Respondr(R) TNF Indicates Likelihood of Patient Response to Costly IBD Treatment Before Initiation of Therapy SAN DIEGO, CA / ACCESS Newswire / April 29, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the novel Responder TNF blood test is now commercially available. Respondr TNF is the first test to predict an inflammatory bowel disease (IBD) patient's likelihood to respond to infliximab, adalimumab and their biosimilars prior to therapy...

UPPSALA, SE / ACCESS Newswire / March 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract with DiviTum TKa in a biomarker algorithm will be presented by Karolinska Institutet (KI) at the annual AACR meeting in Chicago on April 25-30, 2025, providing the first evidence that DiviTum TKa in combination with inflammation protein biomarkers significantly improves the ability to stratify...

The 2023-2024 Georgia Milestones data reveals that third-grade literacy plays a pivotal role in students' long-term success. CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / March 13, 2025 / Third grade can be the make-or-break moment in a student's academic journey, and this year's 2023-2024 Georgia Milestones Assessment data underscores just how critical early literacy is. The results reveal a striking trend: districts that performed well in third grade saw continued success across all future...